Ποια είναι η τιμή για Tien Liang BioTech Co., Ltd. (4127)

Η τιμή για Tien Liang BioTech Co., Ltd. (4127) είναι $2.71

Ποια είναι η κεφαλαιοποίηση αγοράς για Tien Liang BioTech Co., Ltd. (4127)

Η κεφαλαιοποίηση αγοράς για Tien Liang BioTech Co., Ltd. (4127) είναι $124.12M

Tien Liang BioTech Co., Ltd. (4127) Τιμή και Κεφαλαιοποίηση Αγοράς

Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.

Η τιμή για 4127	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$113,885 $124.12M	NVDA	$5.211T	+4,198,502.03%
$99,361.12 $124.12M	AAPL	$4.547T	+3,663,040.60%
$90,963.57 $124.12M	GOOG	$4.162T	+3,353,448.83%
$78,514.11 $124.12M	MSFT	$3.593T	+2,894,475.06%
$61,032.91 $124.12M	AMZN	$2.793T	+2,249,996.68%

Η τιμή για 4127

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$113,885 $124.12M